93 related articles for article (PubMed ID: 23531098)
21. Effectiveness of adjuvant fluorouracil in clinical practice: a population-based cohort study of elderly patients with stage III colon cancer.
Iwashyna TJ; Lamont EB
J Clin Oncol; 2002 Oct; 20(19):3992-8. PubMed ID: 12351596
[TBL] [Abstract][Full Text] [Related]
22. Benefit of Postresection Adjuvant Chemotherapy for Stage III Colon Cancer in Octogenarians: Analysis of the National Cancer Database.
Bergquist JR; Thiels CA; Spindler BA; Shubert CR; Hayman AV; Kelley SR; Larson DW; Habermann EB; Pemberton JH; Mathis KL
Dis Colon Rectum; 2016 Dec; 59(12):1142-1149. PubMed ID: 27824699
[TBL] [Abstract][Full Text] [Related]
23. Effect of Comorbidities in Stage II/III Colorectal Cancer Patients Treated With Surgery and Neoadjuvant/Adjuvant Chemotherapy: A Single-Center, Observational Study.
Baretti M; Rimassa L; Personeni N; Giordano L; Tronconi MC; Pressiani T; Bozzarelli S; Santoro A
Clin Colorectal Cancer; 2018 Sep; 17(3):e489-e498. PubMed ID: 29650416
[TBL] [Abstract][Full Text] [Related]
24. A patient's race/ethnicity does not explain the underuse of appropriate adjuvant therapy in colorectal cancer.
McGory ML; Zingmond DS; Sekeris E; Bastani R; Ko CY
Dis Colon Rectum; 2006 Mar; 49(3):319-29. PubMed ID: 16475031
[TBL] [Abstract][Full Text] [Related]
25. The effect of comorbidity on the use of adjuvant chemotherapy and type of regimen for curatively resected stage III colon cancer patients.
Hsieh MC; Thompson T; Wu XC; Styles T; O'Flarity MB; Morris CR; Chen VW
Cancer Med; 2016 May; 5(5):871-80. PubMed ID: 26773804
[TBL] [Abstract][Full Text] [Related]
26. Surgical treatment of colon cancer in patients aged 80 years and older : analysis of 31,574 patients in the SEER-Medicare database.
Neuman HB; O'Connor ES; Weiss J; Loconte NK; Greenblatt DY; Greenberg CC; Smith MA
Cancer; 2013 Feb; 119(3):639-47. PubMed ID: 22893570
[TBL] [Abstract][Full Text] [Related]
27. Adjuvant 5FU plus levamisole in colonic or rectal cancer: improved survival in stage II and III.
Taal BG; Van Tinteren H; Zoetmulder FA;
Br J Cancer; 2001 Nov; 85(10):1437-43. PubMed ID: 11720425
[TBL] [Abstract][Full Text] [Related]
28. The Value of Continuity between Primary Care and Surgical Care in Colon Cancer.
Hussain T; Chang HY; Luu NP; Pollack CE
PLoS One; 2016; 11(5):e0155789. PubMed ID: 27219454
[TBL] [Abstract][Full Text] [Related]
29. Influence of hospital procedure volume on outcomes following surgery for colon cancer.
Schrag D; Cramer LD; Bach PB; Cohen AM; Warren JL; Begg CB
JAMA; 2000 Dec; 284(23):3028-35. PubMed ID: 11122590
[TBL] [Abstract][Full Text] [Related]
30. Overtreatment of young adults with colon cancer: more intense treatments with unmatched survival gains.
Kneuertz PJ; Chang GJ; Hu CY; Rodriguez-Bigas MA; Eng C; Vilar E; Skibber JM; Feig BW; Cormier JN; You YN
JAMA Surg; 2015 May; 150(5):402-9. PubMed ID: 25806815
[TBL] [Abstract][Full Text] [Related]
31. The interaction between BRAF mutation and microsatellite instability (MSI) status in determining survival outcomes after adjuvant 5FU based chemotherapy in stage III colon cancer.
Chouhan H; Sammour T; Thomas ML; Moore JW
J Surg Oncol; 2018 Dec; 118(8):1311-1317. PubMed ID: 30399198
[TBL] [Abstract][Full Text] [Related]
32. Timing of adjuvant chemotherapy initiation after surgery for stage III colon cancer.
Hershman D; Hall MJ; Wang X; Jacobson JS; McBride R; Grann VR; Neugut AI
Cancer; 2006 Dec; 107(11):2581-8. PubMed ID: 17078055
[TBL] [Abstract][Full Text] [Related]
33. Adherence to treatment guidelines and survival for older patients with stage II or III colon cancer in Texas from 2001 through 2011.
Zhao H; Zhang N; Ho V; Ding M; He W; Niu J; Yang M; Du XL; Zorzi D; Chavez-MacGregor M; Giordano SH
Cancer; 2018 Feb; 124(4):679-687. PubMed ID: 29140558
[TBL] [Abstract][Full Text] [Related]
34. Effect of age on survival benefit of adjuvant chemotherapy in elderly patients with Stage III colon cancer.
Zuckerman IH; Rapp T; Onukwugha E; Davidoff A; Choti MA; Gardner J; Seal B; Mullins CD
J Am Geriatr Soc; 2009 Aug; 57(8):1403-10. PubMed ID: 19563521
[TBL] [Abstract][Full Text] [Related]
35. Racial disparities and socioeconomic status in association with survival in a large population-based cohort of elderly patients with colon cancer.
Du XL; Fang S; Vernon SW; El-Serag H; Shih YT; Davila J; Rasmus ML
Cancer; 2007 Aug; 110(3):660-9. PubMed ID: 17582625
[TBL] [Abstract][Full Text] [Related]
36. The use of chemotherapy in older patients with stage II and III colon cancer: Variation by age and era of diagnosis.
Green SL; Dawe DE; Nugent Z; Cheung WY; Czaykowski PM
J Geriatr Oncol; 2019 Jan; 10(1):132-137. PubMed ID: 30104156
[TBL] [Abstract][Full Text] [Related]
37. Large age and hospital-dependent variation in administration of adjuvant chemotherapy for stage III colon cancer in southern Netherlands.
van Steenbergen LN; Rutten HJT; Creemers GJ; Pruijt JFM; Coebergh JWW; Lemmens VEPP
Ann Oncol; 2010 Jun; 21(6):1273-1278. PubMed ID: 19880434
[TBL] [Abstract][Full Text] [Related]
38. Age-related inequalities in colon cancer treatment persist over time: a population-based analysis.
Hayes L; Forrest L; Adams J; Hidajat M; Ben-Shlomo Y; White M; Sharp L
J Epidemiol Community Health; 2019 Jan; 73(1):34-41. PubMed ID: 30409922
[TBL] [Abstract][Full Text] [Related]
39. TP53 Mutational Status and Prediction of Benefit from Adjuvant 5-Fluorouracil in Stage III Colon Cancer Patients.
Kandioler D; Mittlböck M; Kappel S; Puhalla H; Herbst F; Langner C; Wolf B; Tschmelitsch J; Schippinger W; Steger G; Hofbauer F; Samonigg H; Gnant M; Teleky B; Kührer I;
EBioMedicine; 2015 Aug; 2(8):825-30. PubMed ID: 26425688
[TBL] [Abstract][Full Text] [Related]
40. Use of Bevacizumab for Elderly Patients With Stage IV Colon Cancer: Analysis of SEER-Medicare Data.
Raab GT; Lin A; Hillyer GC; Keller D; O'Neil DS; Accordino MK; Buono DL; Hur C; Kiran RP; Wright JD; Hershman DL; Neugut AI
Clin Colorectal Cancer; 2019 Sep; 18(3):e294-e299. PubMed ID: 31266707
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
